An Update on Hepatobiliary and Pancreatic Cancer
Hear about new developments and current treatment algorithms for hepatocellular carcinoma, recent advances in systemic therapy for biliary tract cancers, and updates in the diagnosis and treatment of pancreatic cancer.
Presented by: William Harris, MD Associate Professor, Division of Oncology University of Washington School of Medicine; Seattle Cancer Care Alliance
This webinar is part of a six-part clinical education series hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers.
ADDITIONAL HANDOUTS TO SUPPLEMENT YOUR LEARNING
The Hawaii Society of Clinical Oncology (HSCO) is a Chapter Member of the Association of Community Cancer Centers (ACCC). HSCO members receive access to valuable educational content and targeted resources through ACCC to support their professional development.
· In partnership with the Cancer Support Community, the American Cancer Society, and the Global Liver Institute, ACCC developed the Multidisciplinary Hepatocellular Carcinoma Care (HCC) education project, which includes an environmental scan of the current HCC care delivery landscape; a comprehensive literature review; and insights from the project’s advisory committee.
· The ACCC COVID-19 Resource Center contains webcasts, podcasts, and blogs, and resources on the pandemic from federal and professional organizations.
· The ACCC COVID-19 Financial Advocacy Resources Hub features new and updated foundation assistance, updates to manufacturer assistance programs, and Medicare and Medicaid coverage updates.
· HSCO members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, HSCO members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience. Join the discussion and connect with your peers.
· Tap into the value of HSCO membership! Visit our membership page for more information on how you can join our community of professionals. If you’re unsure of your membership status, please contact our membership department today.
· The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today!
William Harris, MD
Associate Professor, Division of Oncology University of Washington School of Medicine Seattle Cancer Care Alliance
Dr. Harris received his BS. from Brown University, Providence, RI and his MD from Columbia University College of Physicians and Surgeons, New York, NY. He completed his Internal Medicine Residency at the University of Washington, Seattle, WA. Dr. Harris completed his Post-Doctoral Fellowship in Medical Oncology at the University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.
Shane Morita, MD, PhD, FACS (Moderator)
Program Director, Surgical Oncology The Queen's Medical Center
Shane Morita, MD, MS, PhD, FACS, is the surgical oncology program director at The Queen’s Medical Center/Queen’s Cancer Center and is part of the clinical faculty for the John A. Burns School of Medicine and the University of Hawaii Cancer Center. He is actively involved in program development for the Queen’s multidisciplinary cancer clinic and conducts research centered on molecular pathways and ethnic disparity of cancer in Hawaii, including thyroid carcinoma and cutaneous melanoma.
Additionally, Dr. Morita is the incoming Chair for the State of Hawaii Comprehensive Cancer Control Coalition and an active board member of the American Cancer Society Hawaii-Pacific chapter. He has received numerous awards for his research and was the sole recipient of the NCCTG junior faculty grant from the Mayo Clinic.
- Imbruvica® (IBRUTINIB) Prescribing Information
- Imbruvica® Clinical Information I
- Imbruvica® Patient Support